Results 191 to 200 of about 6,419 (213)

Cholesterol-lowering Drugs for High-Risk Hypercholesterolemia Patients with COVID-19 While on Paxlovid™ Therapy

Future Virology, 2022
Alpo Vuorio, Frederick J Raal
exaly  

Postmarketing Reporting of Paxlovid‐Related Dysgeusia: A Real‐World Pharmacovigilance Study

Otolaryngology - Head and Neck Surgery, 2023
Ashton E Lehmann, Ian M Humphreys, Neel K Bhatt   +2 more
exaly  

Les bénéfices thérapeutiques du Paxlovid®

La Presse Médicale Formation, 2023
openaire   +1 more source

Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID‐19: An updated meta‐analysis and trial sequential analysis

Reviews in Medical Virology, 2023
Haokun Tian
exaly  

Paxlovid Alternative Is Similarly Effective

JAMA, 2023
openaire   +1 more source

Efficacy and safety of Paxlovid for COVID-19:a meta-analysis

Journal of Infection, 2023
Feng Zhanhui
exaly  

Paxlovid and tacrolimus drug interaction

Reactions Weekly, 2023
openaire   +1 more source

Paxlovid: risk of drug interactions

Reactions Weekly, 2023
openaire   +1 more source

Barriers to Worldwide Access for Paxlovid, a New Treatment for COVID-19

Open Forum Infectious Diseases, 2022
Toby Pepperrell, Junzheng Wang, Andrew M Hill   +2 more
exaly  

Paxlovid-Induced SIADH

American Journal of Respiratory and Critical Care Medicine
S. Goyal, V. Vedantam
openaire   +1 more source